title: CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine A is still required to reduce GVHD and morbidity.
authors.affiliation: Johns Hopkins Bone Marrow Transplantation Unit, Baltimore, Maryland, USA.
authors.forename: S J
authors.initials: SJ
authors.lastname: Noga
authors.forename: G B
authors.initials: GB
authors.lastname: Vogelsang
authors.forename: A
authors.initials: A
authors.lastname: Seber
authors.forename: J M
authors.initials: JM
authors.lastname: Davis
authors.forename: K
authors.initials: K
authors.lastname: Schepers
authors.forename: A D
authors.initials: AD
authors.lastname: Hess
authors.forename: R J
authors.initials: RJ
authors.lastname: Jones
mesh_terms: D000328:Adult; D015703:Antigens, CD; D018952:Antigens, CD34; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002469:Cell Separation; D003114:Colony-Forming Units Assay; D016572:Cyclosporine / Q000627:therapeutic use*; D006086:Graft vs Host Disease / Q000453:epidemiology / Q000517:prevention & control*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D008875:Middle Aged; D009017:Morbidity; D009190:Myelodysplastic Syndromes / Q000628:therapy; D018579:Patient Selection; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D014184:Transplantation, Homologous
chemical_list: D015703:Antigens, CD; D018952:Antigens, CD34; D007166:Immunosuppressive Agents; D016572:Cyclosporine